Board of Directors

David is the Founder, Chairman, and CEO of Weild & Co.   The studies that he co-authored have documented the long-term decline in equity capital formation in the United States and provided the core arguments that gave rise to the JOBS Act and many of the specific provisions contained in the JOBS Act.   For these reasons, he has been called “The father of the JOBS Act.”  David has also called for a “JOBS Act 2” or “JOBS Act Part 2”  -  language increasingly heard on Capitol Hill.  The work has been cited by a broad range of legislators, regulators, academics, the IPO Task Force, and the White House Jobs Council leading up to the JOBS Act.  David has testified in Congress (most recently in June 2013) and at the SEC (most recently at the Roundtable on Decimalization) on these and other market issues and attended the signing of the JOBS Act by President Obama in the Rose Garden on April 5, 2012. 

David was also recently asked to author a study for the Organization of Economic Cooperation and Development (OECD) which was entitled, “Making Stock Markets Work to Support Economic Growth” and presented in April 2013 in draft form to the 35 member nations of the OECD, IOSCO and the European Commission.  The U.S. Treasury and SEC were in attendance.   He later presented the final version at a meeting in June that included the CEO of the World Federation of Exchanges where it was generally agreed, as Weild and Kim have maintained,  that structural changes to stock markets have caused the global decline in capital formation for small companies.

David is a former Vice Chairman and executive committee member of The NASDAQ Stock Market and spent years running Wall Street investment banking and equity capital markets businesses.   

David holds an MBA from the Stern School of Business and a BA from Wesleyan University. He studied on exchange at The Sorbonne, Ecole des Haute Etudes Commerciales and The Stockholm School of Economics.   He is also Chairman of the Board of Tuesday’s Children, the 9/11 charity.

Kevin Davis is an executive and lawyer with a broad range of experience in buying, building, and running businesses as well as private equity/venture capital and in life sciences.

Mr. Davis is CEO of Molecular Defenses Corporation, a therapeutic technology company with a portfolio of proprietary, patented, and patent-pending innovative, safe, intracellular bimolecular therapeutics.

Kevin is a partner of Avira Capital, LLC., a firm focused on healthcare and natural resources. Avira’s partners include CLSA, a subsidiary of CITIC, China’s largest conglomerate and Asia’s largest financial firm.

Mr. Davis is also a partner at Advocatus LLP, a law firm exclusively focused on international public interest cases. Advocatus lawyers bring actions against terrorists, war criminals, and others who would deprive innocents of their rights.

Mr. Davis is a member of the Bar of the District of Columbia and is a graduate of Princeton University and Harvard Law School.

Chip Dempsey was until recently an Executive Director with Morgan Stanley's Principal Strategic Investments group where he invested globally on behalf of the firm in FinTech and market structure ventures.  As a seasoned executive, sales rainmaker and team builder, Chip worked closely with portfolio company management teams, contributing to their success for Morgan Stanley.  Chip’s views are informed by first-hand operating experience.  He held a number of senior management, sales and trading roles at firms including:  The Clearing Corp.,  CQG, SunGard Futures Systems,  Logical Information Machines, Rabobank and Chemical Bank.  His areas of interest and investment theses include semantic artificial intelligence, emerging market exchanges and financial inclusion, crypto-currencies & distributed ledgers, and global opportunities for small-scale capital formation.

Chip holds a BA in Philosophy and Economics from Boston College.

Daniel DeWolf has served on the Weild & Co. Board of Directors since 2014.  Daniel is partner at Mintz Levin where he is Chair of the Technology Practice Group and Co-Chair of the Venture Capital and Emerging Companies Practice Group, and is a former Managing Director and Head of Venture Capital Funds at Wit Capital (the first online investment bank).  In addition to his active legal practice, he is an adjunct professor of law at the NYU Law School and he has a wealth of experience in private equity and venture capital, having co-founded Dawntreader Ventures, an early stage venture capital firm based in New York. Daniel has more than 30 years of corporate transactional experience, both as a lawyer and as a businessman, and has been an advisor to many emerging and developmental stage companies.  He is a board member of several technology companies and a managing director of Dawntreader Ventures. 

Dan holds a BA and JD from the University of Pennsylvania and is licensed to practice law in the states of New York, New Jersey and California.